Nordea Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.39M | Buy |
|
|||||
|
2025
Q2 | $6.25M | Buy |
|
|||||
|
2025
Q1 | $4.31M | Buy |
|
|||||
|
2024
Q4 | $4.91M | Buy |
|
|||||
|
2024
Q3 | $5.66M | Sell |
|
|||||
|
2024
Q2 | $6.9M | Sell |
|
|||||
|
2024
Q1 | $10.3M | Buy |
|
|||||
|
2023
Q4 | $6.68M | Sell |
|
|||||
|
2023
Q3 | $5.04M | Buy |
|
|||||
|
2023
Q2 | $5.49M | Sell |
|
|||||
|
2023
Q1 | $4.55M | Sell |
|
|||||
|
2022
Q4 | $4.05M | Buy |
|
|||||
|
2022
Q3 | $5.79M | Sell |
|
|||||
|
2022
Q2 | $5.39M | Sell |
|
|||||
|
2022
Q1 | $6.27M | Buy |
|
|||||
|
2021
Q4 | $7.55M | Buy |
|
|||||
|
2021
Q3 | $8.5M | Buy |
|